Erste Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-23,000
| Closed | -$2.32M | – | 937 |
|
|
2023
Q2 | $2.32M | Hold |
23,000
| – | – | 0.04% | 271 |
|
|
2023
Q1 | $2.07M | Buy |
+23,000
| New | +$2.07M | 0.04% | 284 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 962 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 933 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 954 |
|
|
2022
Q1 | – | Sell |
-6,700
| Closed | -$172K | – | 910 |
|
|
2021
Q4 | $172K | Sell |
6,700
-11,000
| -62% | -$282K | ﹤0.01% | 496 |
|
|
2021
Q3 | $1.86M | Hold |
17,700
| – | – | 0.04% | 281 |
|
|
2021
Q2 | $2.6M | Hold |
17,700
| – | – | 0.05% | 263 |
|
|
2021
Q1 | $1.72M | Hold |
17,700
| – | – | 0.04% | 290 |
|
|
2020
Q4 | $2.3M | Sell |
17,700
-4,900
| -22% | -$636K | 0.06% | 249 |
|
|
2020
Q3 | $2.14M | Hold |
22,600
| – | – | 0.07% | 238 |
|
|
2020
Q2 | $3.48M | Hold |
22,600
| – | – | 0.14% | 165 |
|
|
2020
Q1 | $3.66M | Hold |
22,600
| – | – | 0.21% | 124 |
|
|
2019
Q4 | $4.78M | Hold |
22,600
| – | – | 0.21% | 117 |
|
|
2019
Q3 | $1.9M | Hold |
22,600
| – | – | 0.1% | 191 |
|
|
2019
Q2 | $2.07M | Buy |
+22,600
| New | +$2.07M | 0.11% | 170 |
|